Rhode Island Hospital recently announced that it is the first hospital in North America to install the innovative QIAcuityDx machine. This cutting-edge, revolutionary technology will leverage RNA sequencing to transform clinical testing, offering highly precise quantitation of pathogen RNA targets. While marketed by Qiagen, the QIAcuityDx is set to enhance monitoring of cancer progression and streamline less invasive liquid biopsies. However, this machine will be used initially to better diagnose pathogens causing sepsis.
In a groundbreaking application, Rhode Island Hospital will be the first to utilize the QIAcuitySx technology to test new technologies to diagnose sepsis—a critical condition that accounts for 20% of deaths worldwide. This initiative aims to improve diagnosis and treatment for patients suffering from sepsis, a life-threatening response to infection that can lead to tissue damage and organ failure.
“We are excited to be at the forefront of this important research,” said Sean Monaghan, MD, trauma surgeon at Brown Surgical Associates and Rhode Island Hospital. “The QIAcuityDx will allow us to apply cutting-edge technology in the fight against sepsis, improving outcomes for our patients and paving the way for future advancements in precision medicine.”
The research will employ deep RNA sequencing of whole blood samples from sepsis patients to create targets for use on the QIAcuity Dx, enabling the identification of the pathogens responsible for the disease. This knowledge will facilitate better resource allocation, predict patient outcomes, and uncover novel therapeutic targets.
The installation of the QIAcuityDx at Rhode Island Hospital this week represents a significant milestone in the hospital’s commitment to leveraging innovative technologies for improved patient care and outcomes.
IN THE NEWS:
- BrownHealth: Rhode Island Hospital Becomes First Hospital in North America to Install QIAcuityDx
- Channel 10: Rhode Island Hospital first in North America to install revolutionary technology
- PBN: Five Questions with Dr. Monaghan
